China: Preferential Tax Treatment for Equity Incentive Income Gets Extended Until 31 December 2023

In brief

On 16 January 2023, the PRC Ministry of Finance (MOF) and the State Taxation Administration (STA) jointly issued Bulletin [2023] No. 21 (“Bulletin 2”) to extend the preferential individual income tax (IIT) treatment for equity incentive income for one additional year with effect until 31 December 2023. Taxpayers can continue enjoying preferential IIT treatment on equity incentive income, annual bonus and expatriates' allowances in 2023.


Contents

Key takeaways

The extension of the IIT preferential treatment for equity incentive income is welcome news for taxpayers.

Meanwhile, it is important to note that the Chinese tax authority has been strengthening the IIT compliance administration relating to equity incentive income. During the past year, we have seen local tax bureaus actively enforcing the reporting requirements imposed under Shui Zong Ke Fa [2021] No. 692 ("Notice 69") on equity incentive income. In some cities, in addition to the grant and/or vesting filings in accordance with Cai Shui [2005] No. 353, Notice 69 filings must be completed in order for the relevant employees to enjoy the preferential IIT treatment.

In light of this practical environment, companies are recommended to take measures to ensure the compliance with their IIT withholding and/or reporting obligations and address historic non-compliances (if any).

In more detail

The prevailing preferential individual income tax (IIT) policy for equity incentive income as provided under Cai Shui [2018] No. 1644 (“Notice 164”) was originally set to expire by the end of 2021. On 31 December 2021, the MOF and STA jointly issued Bulletin [2021] No. 425 ("Bulletin 42") which granted a one-year extension for the preferential IIT treatment for equity incentive income.

More recently, on 16 January 2023, the MOF and STA issued Bulletin 2 to further extend the preferential IIT treatment for equity incentive income for one additional year. Pursuant to Bulletin 2, PRC tax resident employees can continue enjoying preferential IIT treatment on qualified equity incentive income for the period from 1 January 2023 to 31 December 2023.

It is not surprising to see the preferential IIT policy on equity incentive income was further extended. In fact, it is common for the Chinese government to first set a limited effective period for tax incentives and then grant extensions from time to time. This approach provides the Chinese government the flexibility on whether to continue granting the relevant tax incentives depending on the specific circumstances.

In addition to equity incentive income, the prevailing preferential IIT treatments for annual bonus and expatriates' allowances are also scheduled to expire by the end of 2023. It remains to be seen if these preferential IIT policies would be further extended after 2023.

1 Bulletin of the PRC Ministry of Finance and the State Taxation Administration Relating to the Extension of Certain Preferential Individual Income Tax Policies, MOF and STA Bulletin [2023] No. 2, dated 16 January 2023 and retroactively effective as of 1 January 2023.
2 Notice of the State Taxation Administration on Certain Measures to Deepen the "Fang Guan Fu" Reform in the Tax Area and to Foster and Stimulate the Vitality of Market Players, Shui Zong Ke Fa [2021] No. 69, dated 12 October 2021 and effective as of the same date.
3 Notice of the PRC Ministry of Finance and the State Taxation Administration Relating to the Collection of Individual Income Tax on Stock Option Income, Cai Shui [2005] No. 35, dated 28 March 2005 and effective from 1 July 2005.
4 Notice of the PRC Ministry of Finance and the State Taxation Administration on the Transition of Relevant Preferential Tax Policies after the Amendment of the Individual Income Tax Law, Cai Shui [2018] No. 164, dated 27 December 2018 and effective as of 1 January 2019.

 


LOGO BM-FenXun bold-RGB (003)

Baker & McKenzie FenXun (FTZ) Joint Operation Office is a joint operation between Baker & McKenzie LLP, an Illinois limited liability partnership, and FenXun Partners, a Chinese law firm. The Joint Operation has been approved by the Shanghai Justice Bureau. In accordance with the common terminology used in professional service organisations, reference to a "partner" means a person who is a partner, or equivalent, in such a law firm.  This may qualify as “Attorney Advertising” requiring notice in some jurisdictions.  Prior results do not guarantee a similar outcome.

This client alert has been prepared for clients and professional associates of Baker & McKenzie FenXun (FTZ) Joint Operation Office. Whilst every effort has been made to ensure accuracy, this client alert is not an exhaustive treatment of the area of law discussed and no responsibility for any loss occasioned to any person acting or refraining from action as a result of material in this presentation is accepted by Baker & McKenzie FenXun (FTZ) Joint Operation Office.
 

Contact Information
Amy Ling
Registered Foreign Lawyer
Hong Kong
Read my Bio
amy.ling@bakermckenzie.com
Jason Wen
Senior Tax Consulting Director at BakerMcKenzie
Beijing
Read my Bio
jason.wen@bakermckenziefenxun.com
Luis Zhang
Senior Counsel at BakerMcKenzie
Shanghai
Read my Bio
luis.zhang@bakermckenziefenxun.com
Clive Gu
Associate at BakerMcKenzie
Shanghai
clive.gu@bakermckenziefenxun.com

Copyright © 2024 Baker & McKenzie. All rights reserved. Ownership: This documentation and content (Content) is a proprietary resource owned exclusively by Baker McKenzie (meaning Baker & McKenzie International and its member firms). The Content is protected under international copyright conventions. Use of this Content does not of itself create a contractual relationship, nor any attorney/client relationship, between Baker McKenzie and any person. Non-reliance and exclusion: All Content is for informational purposes only and may not reflect the most current legal and regulatory developments. All summaries of the laws, regulations and practice are subject to change. The Content is not offered as legal or professional advice for any specific matter. It is not intended to be a substitute for reference to (and compliance with) the detailed provisions of applicable laws, rules, regulations or forms. Legal advice should always be sought before taking any action or refraining from taking any action based on any Content. Baker McKenzie and the editors and the contributing authors do not guarantee the accuracy of the Content and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the Content. The Content may contain links to external websites and external websites may link to the Content. Baker McKenzie is not responsible for the content or operation of any such external sites and disclaims all liability, howsoever occurring, in respect of the content or operation of any such external websites. Attorney Advertising: This Content may qualify as “Attorney Advertising” requiring notice in some jurisdictions. To the extent that this Content may qualify as Attorney Advertising, PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME. Reproduction: Reproduction of reasonable portions of the Content is permitted provided that (i) such reproductions are made available free of charge and for non-commercial purposes, (ii) such reproductions are properly attributed to Baker McKenzie, (iii) the portion of the Content being reproduced is not altered or made available in a manner that modifies the Content or presents the Content being reproduced in a false light and (iv) notice is made to the disclaimers included on the Content. The permission to re-copy does not allow for incorporation of any substantial portion of the Content in any work or publication, whether in hard copy, electronic or any other form or for commercial purposes.